Heritage Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HERITAGE PHARMA, and what generic and branded alternatives to HERITAGE PHARMA drugs are available?
HERITAGE PHARMA has eighty approved drugs.
Summary for Heritage Pharma
| US Patents: | 0 |
| Tradenames: | 53 |
| Ingredients: | 51 |
| NDAs: | 80 |
| Patent Litigation for Heritage Pharma: | See patent lawsuits for Heritage Pharma |
Drugs and US Patents for Heritage Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heritage Pharma | DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 205210-001 | Feb 13, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Heritage Pharma | LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 076170-001 | Jun 10, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Heritage Pharma | HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | TABLET;ORAL | 204279-003 | Aug 20, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
